| abstract |
The present invention relates to a pharmaceutical composition for the prevention and treatment of cancer diseases. According to the present invention as described above, a novel naphthalenylphenyldihydropyrazole compound (3- (2-hydroxynaphthale) having a growth inhibitory effect of cancer cells through a decrease in the expression level of cyclin D1 (cyclin D1) protein -1-yl) -5- (2-methoxyphenyl) -N- (3,4,5-trimethoxyphenyl) -4,5-dihydropyrazole-1-carbothioamide, 3- ( 2-hydroxynaphthalen-1-yl) -5- (2-methoxyphenyl) -N- (3,4,5-trimethoxyphenyl) -4,5-dihydropyrazole-1-carbothioamide) and for preventing and treating cancer diseases including the same By providing a pharmaceutical composition, there is an effect that can be usefully used to prevent and treat cancer diseases. |